Cargando…

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence

BACKGROUND: Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Beth, Moss, Charlotte, George, Gincy, Santaolalla, Aida, Cope, Andrew, Papa, Sophie, Van Hemelrijck, Mieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105343/ https://www.ncbi.nlm.nih.gov/pubmed/32256705 http://dx.doi.org/10.3332/ecancer.2020.1022

Ejemplares similares

Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
por: Russell, Beth, et al.
Publicado: (2020)

Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?
por: George, Gincy, et al.
Publicado: (2023)

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
por: Chen, Miaoqi, et al.
Publicado: (2021)

Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)

Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic
por: Santaolalla, Aida, et al.
Publicado: (2020)

The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
por: Soualhi, Ahmed, et al.
Publicado: (2021)

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020)

One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer
por: Moss, Charlotte, et al.
Publicado: (2020)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
por: White, Benjamin E., et al.
Publicado: (2022)

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
por: George, Gincy, et al.
Publicado: (2023)

Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review
por: Handford, Jasmine, et al.
Publicado: (2022)

Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases
por: George, Gincy, et al.
Publicado: (2020)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2017)

Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study
por: Bosco, Cecilia, et al.
Publicado: (2015)

An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
por: Moss, Miss Charlotte L., et al.
Publicado: (2021)

Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience
por: Bosco, Cecilia, et al.
Publicado: (2016)

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer
por: Nowinski, Salpie, et al.
Publicado: (2018)

Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022)

Impact of age on the toxicity of immune checkpoint inhibition
por: Samani, Amit, et al.
Publicado: (2020)

The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer
por: Tremble, Kathryn, et al.
Publicado: (2022)

Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic
por: Hadi, Hajer, et al.
Publicado: (2022)

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
por: Santaolalla, Aida, et al.
Publicado: (2019)

Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2021)

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
por: Russell, Beth, et al.
Publicado: (2018)

Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer
por: Wylie, Harriet, et al.
Publicado: (2019)

Real‐world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases
por: George, Gincy, et al.
Publicado: (2019)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
por: So, Alfred Chung Pui, et al.
Publicado: (2021)

A mediation analysis to explain socio‐economic differences in bladder cancer survival
por: Russell, Beth, et al.
Publicado: (2020)

Electromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications
por: Min, Jolene Wong Si, et al.
Publicado: (2022)

Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators
por: Russell, Beth, et al.
Publicado: (2021)

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
por: Santaolalla, Aida, et al.
Publicado: (2021)

Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19
por: So, Alfred Chung Pui, et al.
Publicado: (2022)

Tremor Suppression by Rhythmic Transcranial Current Stimulation
por: Brittain, John-Stuart, et al.
Publicado: (2013)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3caj2vk9ng16uflks6j38h2frn